Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

24th May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,833,192

(2.113%)

-

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

586,200

(0.256%)

1,779,700

(0.778%)

Total

5,419,392

(2.369%)

1,779,700

(0.778%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

a. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

Purchase

25

99.91

Purchase

72

99.92

Purchase

150

99.96

Purchase

25

99.83

Purchase

87

99.95

Purchase

75

99.85

Purchase

75

99.81

Purchase

308

99.68

Purchase

125

99.62

Purchase

250

99.93

Purchase

73

99.50

Purchase

3

99.48

Purchase

25

99.84

Purchase

30

99.51

Sale

73

100.07

Purchase

25

99.72

Purchase

125

99.94

Purchase

391

99.91

Purchase

116

99.92

Purchase

68

99.86

Purchase

65

99.76

Purchase

97

99.95

Purchase

85

99.87

Purchase

1

99.63

Purchase

1,195

99.50

Purchase

18

99.84

Purchase

1

99.51

Purchase

509

99.65

Purchase

82

99.72

Purchase

11

99.78

Purchase

688

99.94

Purchase

2

99.61

Purchase

319

99.91

Purchase

579

99.92

Purchase

167

100.00

Sale

25,000

100.00

Purchase

226

99.86

Purchase

1,860

99.76

Sale

25

99.76

Purchase

235

99.99

Purchase

597

99.83

Sale

20

99.83

Purchase

160

99.70

Sale

3,400

99.70

Purchase

712

99.95

Purchase

360

99.85

Purchase

1,904

99.67

Purchase

500

99.87

Purchase

2,032

99.79

Purchase

4,432

99.74

Sale

655

99.74

Purchase

5,362

99.81

Purchase

100

99.68

Purchase

1,674

99.75

Sale

200

99.75

Purchase

6,936

99.73

Purchase

123

99.62

Sale

50

99.63

Purchase

2,655

99.77

Purchase

1,060

99.64

Sale

10

99.64

Purchase

2,247

99.50

Sale

23

99.50

Purchase

623

99.71

Purchase

100

99.80

Sale

3,604

99.80

Purchase

1,594

99.69

Sale

300

99.69

Purchase

6

99.51

Purchase

230

99.82

Purchase

157

99.54

Sale

3

99.54

Purchase

294

99.65

Sale

6,454

99.65

Sale

1,015

100.07

Purchase

774

99.72

Sale

22

99.72

Purchase

50

99.53

Purchase

16

99.78

Sale

11

99.78

Purchase

690

99.94

Purchase

1,015

99.61

Purchase

449

99.90

Purchase

452

99.66

Purchase

253

99.58

Purchase

54

99.56

Purchase

45

99.55

Purchase

141

99.59

Sale

5

99.92

Sale

3

100.00

Sale

2

99.88

Sale

2

99.76

Sale

2

99.99

Sale

2

99.83

Sale

5

99.70

Sale

3

99.95

Sale

3

99.87

Sale

3

99.74

Sale

1

99.62

Sale

1

99.63

Sale

2

99.98

Sale

1

99.65

Sale

2

100.07

Sale

3

99.78

Sale

10

99.89

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put Option

Selling

50,000

85.00

American

15/09/2023

 

Put Option

Purchased

50,000

85.00

American

17/11/2023

 

Put Option

Purchased

2,600

90.00

American

17/11/2023

 

Put Option

Purchased

40,900

100.00

American

17/11/2023

 

Call Option

Purchased

200

100.00

American

8/18/2023

 

Put Option

Purchased

200

100.00

American

8/18/2023

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

c. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

25th May 2023

Contact name

Stephen Glasper

Telephone number

+44 203 398 2166

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

201,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

50,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

29,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

3,600

105.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

10,900

105.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

99,500

115.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300,000

85.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

283,900

100.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

53,500

95.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

150,000

70.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Purchased

250,000

85.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Purchased

50,000

90.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

50,000

90.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Purchased

50,000

100.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Purchased

125,300

110.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

150,000

100.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Purchased

1,500

110.00

American

17/11/2023

IE00BQPVQZ61

Call Option

Purchased

4,500

110.00

American

10/20/2023

IE00BQPVQZ61

Call Option

Purchased

100,000

100.00

American

12/15/2023

IE00BQPVQZ61

Call Option

Written

100,000

110.00

American

12/15/2023

IE00BQPVQZ61

Put Option

Purchased

100,000

85.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

50,000

101.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

2,800

100.00

American

10/20/2023

IE00BQPVQZ61

Call Option

Purchased

2,800

100.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Written

50,000

85.00

American

15/09/2023

IE00BQPVQZ61

Put Option

Purchased

50,000

85.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Purchased

2,600

90.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Purchased

40,900

100.00

American

17/11/2023

IE00BQPVQZ61

Call Option

Purchased

200

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

200

100.00

American

8/18/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1105023
Time of Receipt (offset from UTC): 20230525T135920+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.